Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The main purpose of this study is to assess the safety and tolerability of AZD0516 as monotherapy and/or in combination with other anti-cancer agents for treatment of metastatic prostate cancer.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony histologicznie lub cytologicznie rak gruczolakowaty prostaty z przerzutami
- •Poziom PSA co najmniej 1 μg/L (co najmniej 1 ng/mL)
- •Chirurgicznie lub medycznie obniżony poziom testosteronu (poniżej 50 ng/dL) - pacjent musi być w stanie kastracji
- •Dobra ogólna kondycja zdrowotna (ECOG 0 lub 1)
- •Prawidłowa praca narządów wewnętrznych i szpiku kostnego
- •Dostępna próbka guza do badania laboratoryjnego
- •Udokumentowany rak prostaty z przerzutami
- •Oczekiwana długość życia co najmniej 12 tygodni
✗ Disqualifies
- •Uciśnięcie rdzenia kręgowego spowodowane rakiem lub przerzuty do mózgu (chyba że bezobjawowe, leczone i stabilne)
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 130 Years
- Last updated (source)
- July 15, 2026
- Sex
- Male only
Therapies / drugs in trial
Locations (52)
Research Site
Fayetteville, United States
Research Site
Los Angeles, United States
Research Site
Towson, United States
Research Site
Boston, United States
Research Site
Ann Arbor, United States
Research Site
Detroit, United States
Research Site
Buffalo, United States
Research Site
New York, United States
Research Site
Providence, United States
Research Site
Myrtle Beach, United States
Research Site
Houston, United States
Research Site
Barretos, Brazil
Research Site
Porto Alegre, Brazil
Research Site
São Paulo, Brazil
Research Site
Changsha, China
Research Site
Chengdu, China
Research Site
Wuhan, China
Research Site
Lyon, France
Research Site
Montpellier, France
Research Site
Saint-Herblain, France
Research Site
Suresnes, France
Research Site
Villejuif, France
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Milan, Italy
Research Site
Naples, Italy
Research Site
Roma, Italy
Research Site
Rozzano, Italy
Research Site
Chūōku, Japan
Research Site
Kashiwa, Japan
Research Site
Kōtoku, Japan
Research Site
Koszalin, Poland
Research Site
Piotrkow Trybunalski, Poland
Research Site
Przemyśl, Poland
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Seoul, South Korea
Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
Barcelona, Spain
Research Site
L'Hospitalet de Llobregat, Spain
Research Site
Madrid, Spain
Research Site
Pamplona, Spain
Research Site
Santander, Spain
Research Site
Valencia, Spain
Research Site
Cambridge, United Kingdom
Research Site
London, United Kingdom
Research Site
London, United Kingdom
Research Site
Plymouth, United Kingdom
Research Site
Sutton, United Kingdom
Trial contact
AstraZeneca Clinical Study Information Center
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/16/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.